Study predicts 2018 flu vaccine will have 20% efficacy
A recent Rice University study predicts the flu vaccine for fall 2018 — a new H3N2 formulation for the first time since 2015 — will likely have the same reduced efficacy against the dominant circulating strain of influenza A as the vaccine given in 2016 and 2017 due to viral mutations related to vac